Caricamento...
Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer
SIMPLE SUMMARY: Doxorubicin (Dox) is a chemotherapeutic agent usually employed for the treatment of breast cancer. However, its use is limited because of the toxicities associated, and hence a proper delivery vehicle is necessary. In this sense, albumin-based nanocarriers are in the limelight for th...
Salvato in:
| Pubblicato in: | Cancers (Basel) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8235501/ https://ncbi.nlm.nih.gov/pubmed/34208533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13123011 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|